NORTHWEST BIOTHERAPEUTICS INC Share Price Today: Live Updates & Key Insights

NORTHWEST BIOTHERAPEUTICS INC share price today is $null, up null%. The stock opened at $null against the previous close of $null, with an intraday high of $null and low of $null.

NORTHWEST BIOTHERAPEUTICS INC Share Price Chart

NORTHWEST BIOTHERAPEUTICS INC

us-stock
To Invest in {{usstockname}}
us-stock

NORTHWEST BIOTHERAPEUTICS INC Share Price Performance

$null null(null%) null at 23 Mar 2026 02:32 PM Biotechnology
Lowest Today 0.00
Highest Today 0.00
Today’s Open 0.00
Prev. Close 0.00
52 Week High 0.48
52 Week Low 0.17
Day’s Range: Low null High null
52-Week Range: Low 0.17 High 0.48
1 day return -
1 Week return -
1 month return -
3 month return -
6 month return -
1 year return -
3 year return -
5 year return -
10 year return -

NORTHWEST BIOTHERAPEUTICS INC Institutional Holdings

NORTHWEST BIOTHERAPEUTICS INC Market Status

NORTHWEST BIOTHERAPEUTICS INC Fundamentals

Market Cap 323.54 M

PB Ratio 75.6193

PE Ratio 0.0

Enterprise Value 400.65 M

Total Assets 26.73 M

Volume null

NORTHWEST BIOTHERAPEUTICS INC Company Financials

Annual Revenue FY23:2084000 2.1M, FY22:1683000 1.7M, FY21:1005000 1.0M, FY20:1291000 1.3M, FY19:2410000 2.4M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:-52702000 -52.7M, FY20:-86605000 -86.6M, FY19:-27463000 -27.5M

Annual Net worth FY23:-71978000 -72.0M, FY22:-105032000 -105.0M, FY21:179126000 179.1M, FY20:-529821000 -529.8M, FY19:-20296000 -20.3M

Quarterly Revenue Q3/2025:200000 0.2M, Q2/2025:131000 0.1M, Q1/2025:375000 0.4M, Q3/2024:357000 0.4M, Q2/2024:510000 0.5M

Quarterly Profit Q3/2025:null 0.0M, Q2/2025:null 0.0M, Q1/2025:null 0.0M, Q3/2024:null 0.0M, Q2/2024:null 0.0M

Quarterly Net worth Q3/2025:-26829000 -26.8M, Q2/2025:-15378000 -15.4M, Q1/2025:-19343000 -19.3M, Q3/2024:-19374000 -19.4M, Q2/2024:-17869000 -17.9M

About NORTHWEST BIOTHERAPEUTICS INC & investment objective

Company Information Northwest Biotherapeutics, Inc., a biotechnology company, focuses on developing personalized immune therapies for cancer. The company develops DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product candidate is the DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct, that has completed Phase I clinical trials to treat inoperable solid tumors, as well as a range of types of cancers. Northwest Biotherapeutics, Inc. was founded in 1996 and is headquartered in Bethesda, Maryland.

Organisation Biotechnology

Employees 25

Industry Biotechnology

CEO Ms. Linda F. Powers J.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

NORTHWEST BIOTHERAPEUTICS INC FAQs

What is the share price of NORTHWEST BIOTHERAPEUTICS INC today?

The current share price of NORTHWEST BIOTHERAPEUTICS INC is $null.

Can I buy NORTHWEST BIOTHERAPEUTICS INC shares in India?

Yes, Indian investors can buy NORTHWEST BIOTHERAPEUTICS INC shares by opening an international trading and demat account with Motilal Oswal.

How to buy NORTHWEST BIOTHERAPEUTICS INC shares in India?

You can easily invest in NORTHWEST BIOTHERAPEUTICS INC shares from India by:

Can I buy fractional shares of NORTHWEST BIOTHERAPEUTICS INC?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of NORTHWEST BIOTHERAPEUTICS INC?

NORTHWEST BIOTHERAPEUTICS INC has a market cap of $323.54 M.

In which sector does NORTHWEST BIOTHERAPEUTICS INC belong?

NORTHWEST BIOTHERAPEUTICS INC operates in the Biotechnology sector.

What documents are required to invest in NORTHWEST BIOTHERAPEUTICS INC stocks?

To invest, you typically need:

What is the PE and PB ratio of NORTHWEST BIOTHERAPEUTICS INC?

The PE ratio of NORTHWEST BIOTHERAPEUTICS INC is N/A and the PB ratio is 75.62.